← All modalities

AAV · LENTIVIRAL

Gene therapies and viral vectors

Keep the cell system, seed train, transfection or infection, bioreactor records, harvest and purification together. Evaluate vector yield alongside the quality measurements and process context needed to interpret it.

Gene therapies and viral vectors workflow from Cell system, Transfection, Harvest, Purification connected through Bio Hub, Bio Twin, Bio Agents and Bio OS

MODALITY-SPECIFIC PROCESS INTELLIGENCE

Connect vector production with analytical quality.

  1. 01Cell system
  2. 02Transfection
  3. 03Harvest
  4. 04Purification
SCIENTIFIC WORKFLOW

Production context

Connect cell-line and seed-train information with reagent and transfection or infection conditions.

SCIENTIFIC WORKFLOW

Harvest strategy

Compare process timing, cell state and vector measurements to assess harvest-related trade-offs.

SCIENTIFIC WORKFLOW

Purification performance

Review recovery and quality evidence across purification stages and batches.

SCIENTIFIC WORKFLOW

Transfer assessment

Bring equipment and process differences into a scientific comparison before selecting scale-up or transfer studies.

EVIDENCE · MODELS · DECISIONS

Keep every conclusion connected.

Evidence in Bio Hub

  • Cell line, seed train and reagent context
  • Transfection, infection and reactor records
  • Vector yield, full/empty, purity and potency assays

Models in Bio Twin

  • Production and process sensitivity
  • Harvest and purification comparisons
  • Scale-up scenario assessment

Scientific decisions

  • Compare transfection and harvest conditions
  • Investigate yield-quality trade-offs
  • Evaluate transfer readiness

Process outcomes to evaluate: Vector yield · purity · potency

EXAMPLE INVESTIGATION

Did a higher vector yield preserve the required quality profile?

01

Connect evidence

Connect production conditions and reagent context with batch and sample identities.

02

Compare context

Compare harvest timing and vector measurements across the selected cohorts.

03

Evaluate explanations

Review full/empty, purity and potency-related assays alongside purification recovery.

04

Review next steps

Prepare the yield-quality comparison and propose the evidence needed to resolve remaining uncertainty.

Bio Agents can coordinate the scientific work across evidence and models, while Bio OS preserves governance and human review. The configured workflow determines which tasks and models are available.

Bring us this process challenge ↗

EVALUATION & SCOPE

Make the demonstration specific.

Vector type, analytical method, host and process stage determine the scope of a comparison. Demonstrated support for one vector workflow should not be assumed to apply unchanged to every vector platform.

What evidence should we bring?

Cell line, seed train and reagent context. Transfection, infection and reactor records. Vector yield, full/empty, purity and potency assays. Include the process question, relevant run context and the analytical methods used to assess the outcome.

How do models support the workflow?

Production and process sensitivity. Harvest and purification comparisons. Scale-up scenario assessment. Scope and evaluation criteria are defined for your process, data and intended decision.

What should we validate before using the results?

Vector type, analytical method, host and process stage determine the scope of a comparison. Demonstrated support for one vector workflow should not be assumed to apply unchanged to every vector platform.

EXPLORE OTHER MODALITIES